A detailed history of Affinity Asset Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 15,000 shares of BMRN stock, worth $994,049. This represents 0.18% of its overall portfolio holdings.

Number of Shares
15,000
Holding current value
$994,049
% of portfolio
0.18%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$69.02 - $93.84 $1.04 Million - $1.41 Million
15,000 New
15,000 $1.05 Million
Q1 2023

May 15, 2023

SELL
$87.74 - $117.27 $4.83 Million - $6.45 Million
-55,000 Reduced 68.75%
25,000 $2.43 Million
Q4 2022

Feb 13, 2023

BUY
$80.93 - $108.63 $6.47 Million - $8.69 Million
80,000 New
80,000 $8.28 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.